Volume 72, Issue 4
BIOMETRIC METHODOLOGY

Simultaneous inference on treatment effects in survival studies with factorial designs

Dan‐Yu Lin

Corresponding Author

E-mail address: lin@bios.unc.edu

Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina 27599, U.S.A.

email: lin@bios.unc.edu

Search for more papers by this author
Jianjian Gong

Novartis Pharmaceuticals Corporation, 59 Route 10, East Hanover, New Jersey 07936, U.S.A.

Search for more papers by this author
Paul Gallo

Novartis Pharmaceuticals Corporation, 59 Route 10, East Hanover, New Jersey 07936, U.S.A.

Search for more papers by this author
Paul H. Bunn

Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina 27599, U.S.A.

Search for more papers by this author
David Couper

Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina 27599, U.S.A.

Search for more papers by this author
First published: 17 March 2016
Citations: 1

Summary

A clinical trial with a urn:x-wiley:15410420:media:biom12507:biom12507-math-0001 factorial design involves randomization of subjects to treatment A or urn:x-wiley:15410420:media:biom12507:biom12507-math-0002 and, within each group, further randomization to treatment B or urn:x-wiley:15410420:media:biom12507:biom12507-math-0003. Under this design, one can assess the effects of treatments A and B on a clinical endpoint using all patients. One may additionally compare treatment A, treatment B, or combination therapy urn:x-wiley:15410420:media:biom12507:biom12507-math-0004 to urn:x-wiley:15410420:media:biom12507:biom12507-math-0005. With multiple comparisons, however, it may be desirable to control the overall type I error, especially for regulatory purposes. Because the subjects overlap in the comparisons, the test statistics are generally correlated. By accounting for the correlations, one can achieve higher statistical power compared to the conventional Bonferroni correction. Herein, we derive the correlation between any two (stratified or unstratified) log‐rank statistics for a urn:x-wiley:15410420:media:biom12507:biom12507-math-0006 factorial design with a survival time endpoint, such that the overall type I error for multiple treatment comparisons can be properly controlled. In addition, we allow for adjustment of prognostic factors in the treatment comparisons and conduct simultaneous inference on the effect sizes. We use simulation studies to show that the proposed methods perform well in realistic situations. We then provide an application to a recently completed randomized controlled clinical trial on alcohol dependence. Finally, we discuss extensions of our approach to other factorial designs and multiple endpoints.

Number of times cited according to CrossRef: 1

  • Power and sample size for dose‐finding studies with survival endpoints under model uncertainty, Biometrics, 10.1111/biom.12968, 75, 1, (308-314), (2018).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.